Recap: Collegium Pharmaceutical Q1 Earnings


Collegium Pharmaceutical COLL reported its Q1 earnings results on Thursday, May 4, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.


Collegium Pharmaceutical beat estimated earnings by 325.81%, reporting an EPS of $1.32 versus an estimate of $0.31.

Revenue was up $61.02 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $1.23 which was followed by a 0.94% increase in the share price the next day.

Here's a look at Collegium Pharmaceutical's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.14 -0.13 1.45 0.90
EPS Actual 1.09 1.10 0.33 0.42
Revenue Estimate 125.19M 124.45M 121.80M 78.88M
Revenue Actual 129.62M 127.01M 123.55M 83.75M

To track all earnings releases for Collegium Pharmaceutical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!